NCT05498727View on ClinicalTrials.gov

Evaluation of the Integration of Ag-RDTs for COVID-19 in MNCH, HIV and TB Services in Cameroon and Kenya

CompletedOBSERVATIONAL
Enrollment

527,184

Participants

Timeline

Start Date

May 2, 2022

Primary Completion Date

October 31, 2022

Study Completion Date

September 30, 2023

Conditions
COVID-19
Interventions
DIAGNOSTIC_TEST

Integration of SARS-CoV 2 Testing in HIV, MNCH and TB Clinics

This study employs a quasi-experimental pre-and-post SARS-CoV-2 Ag-RDT integration design in all facilities implementing the 61 facilities in Cameroon and Kenya in Cameroon and Kenya.

Trial Locations (2)

Unknown

Health facilities in Cameroon, Yaoundé

Health facilities in Kenya, Nairobi

All Listed Sponsors
collaborator

UNITAID

OTHER

collaborator

Kenya Ministry of Health

OTHER_GOV

collaborator

Ministry of Public Health, Cameroon

UNKNOWN

lead

Elizabeth Glaser Pediatric AIDS Foundation

OTHER